Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$780K Buy
26,025
+18,677
+254% +$593K 0.01% 1201
2025
Q4
$215K Buy
+7,348
New +$195K ﹤0.01% 1934
2018
Q4
Sell
-17,525
Closed -$284K 959
2018
Q3
$284K Buy
17,525
+685
+4% +$11K 0.01% 787
2018
Q2
$266K Buy
16,840
+2,195
+15% +$37.9K 0.01% 772
2018
Q1
$263K Sell
14,645
-955
-6% -$17.3K 0.01% 720
2017
Q4
$265K Buy
15,600
+1,400
+10% +$23.7K 0.01% 693
2017
Q3
$230K Buy
+14,200
New +$228K 0.01% 696
2017
Q2
Sell
-13,550
Closed -$201K 775
2017
Q1
$201K Buy
13,550
+130
+1% +$2.02K 0.01% 654
2016
Q4
$209K Buy
+13,420
New +$206K 0.02% 591

Other funds holding IX

Atria Investments's IX Position: Q1 2026 in Review

Atria Investments increased its ORIX (IX) stake by 254% in Q1 2026, buying an estimated $593K and bringing the position to 26,025 shares worth $780K. The position accounts for 0.01% of the portfolio, ranked #1201.

Atria Investments first reported a position in IX in Q4 2016 and has held it in 9 quarters since. 280 funds tracked by Wall St. Rank hold IX as of Q1 2026.

  • Atria Investments held 26,025 shares of ORIX worth $780K as of Q1 2026.
  • Atria Investments bought 18,677 ORIX shares in Q1 2026, an estimated $593K.
  • ORIX made up 0.01% of Atria Investments's portfolio in Q1 2026, its #1201 holding.
  • Atria Investments first reported a position in ORIX in Q4 2016 and has held it in 9 quarters since.
  • 280 funds tracked by Wall St. Rank held ORIX as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.